The company will submit its comprehensive response on these observations to the USFDA
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
This product will be manufactured at Lupin's Pithampur facility in India
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments
Subscribe To Our Newsletter & Stay Updated